Mendelian randomization: genetic anchors for causal inference in epidemiological studies
- PMID: 25064373
- PMCID: PMC4170722
- DOI: 10.1093/hmg/ddu328
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Abstract
Observational epidemiological studies are prone to confounding, reverse causation and various biases and have generated findings that have proved to be unreliable indicators of the causal effects of modifiable exposures on disease outcomes. Mendelian randomization (MR) is a method that utilizes genetic variants that are robustly associated with such modifiable exposures to generate more reliable evidence regarding which interventions should produce health benefits. The approach is being widely applied, and various ways to strengthen inference given the known potential limitations of MR are now available. Developments of MR, including two-sample MR, bidirectional MR, network MR, two-step MR, factorial MR and multiphenotype MR, are outlined in this review. The integration of genetic information into population-based epidemiological studies presents translational opportunities, which capitalize on the investment in genomic discovery research.
© The Author 2014. Published by Oxford University Press.
Figures


Similar articles
-
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):995-1010. doi: 10.1158/1055-9965.EPI-17-1177. Epub 2018 Jun 25. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29941659 Free PMC article. Review.
-
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer.Cancer Causes Control. 2022 May;33(5):631-652. doi: 10.1007/s10552-022-01562-1. Epub 2022 Mar 11. Cancer Causes Control. 2022. PMID: 35274198 Free PMC article.
-
'Mendelian randomization': an approach for exploring causal relations in epidemiology.Public Health. 2017 Apr;145:113-119. doi: 10.1016/j.puhe.2016.12.033. Epub 2017 Jan 21. Public Health. 2017. PMID: 28359378 Review.
-
Mendelian randomization studies on atherosclerotic cardiovascular disease: evidence and limitations.Sci China Life Sci. 2019 Jun;62(6):758-770. doi: 10.1007/s11427-019-9537-4. Epub 2019 May 17. Sci China Life Sci. 2019. PMID: 31104264 Review.
-
Extending Causality Tests with Genetic Instruments: An Integration of Mendelian Randomization with the Classical Twin Design.Behav Genet. 2018 Jul;48(4):337-349. doi: 10.1007/s10519-018-9904-4. Epub 2018 Jun 7. Behav Genet. 2018. PMID: 29882082 Free PMC article.
Cited by
-
Genetic Evidence for the Causal Relationship Between Gut Microbiota and Diabetic Kidney Disease: A Bidirectional, Two-Sample Mendelian Randomisation Study.J Diabetes Res. 2024 Oct 23;2024:4545595. doi: 10.1155/2024/4545595. eCollection 2024. J Diabetes Res. 2024. PMID: 39479291 Free PMC article.
-
Revealing the association between East Asian oral microbiome and colorectal cancer through Mendelian randomization and multi-omics analysis.Front Cell Infect Microbiol. 2024 Sep 17;14:1452392. doi: 10.3389/fcimb.2024.1452392. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39355266 Free PMC article.
-
Causal association between hyperthyroidism and risk of gastroesophageal reflux or esophageal cancer: a bidirectional Mendelian randomization investigation.Front Endocrinol (Lausanne). 2024 Sep 17;15:1411629. doi: 10.3389/fendo.2024.1411629. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39355614 Free PMC article.
-
Causal Effects of Gut Microbiota and Metabolites on Chronic Obstructive Pulmonary Disease: A Bidirectional Two Sample Mendelian Randomization Study.Int J Chron Obstruct Pulmon Dis. 2024 Sep 28;19:2153-2167. doi: 10.2147/COPD.S472218. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39360021 Free PMC article.
-
Causal relationship between human blood metabolites and risk of ischemic stroke: a Mendelian randomization study.Front Genet. 2024 Jan 19;15:1333454. doi: 10.3389/fgene.2024.1333454. eCollection 2024. Front Genet. 2024. PMID: 38313676 Free PMC article.
References
-
- Davey Smith G., Ebrahim S. Epidemiology—is it time to call it a day? Int. J. Epidemiol. 2001;30:1–11. - PubMed
-
- Davey Smith G., Ebrahim G. Folate Supplementation and cardiovascular disease. Lancet. 2005;366:1679–1681. - PubMed
-
- Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J., Komajda M., Lopez-Sendon J., Mosca L., Tardif J.C., Waters D.D., et al. ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 2007;357:2109–2122. - PubMed
-
- Fewell Z., Davey Smith G., Sterne J.A.C. The impact of residual and unmeasured confounding in epidemiological studies; a simulation study. Am. J. Epidemiol. 2007;166:646–655. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources